These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28538504)

  • 1. Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the Literature.
    Benitez LL; Gharibian K; Frame D; Mody R; Mora E
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):481-484. PubMed ID: 28538504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodialysis on the plasma levels of clofarabine.
    Steinherz PG; Shukla N; Kobos R; Latcha S
    Pediatr Blood Cancer; 2010 Jul; 55(1):196-8. PubMed ID: 20232428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of clofarabine in adult patients with acute myeloid leukemia in Japan.
    Suzuki T; Yamauchi T; Ando K; Nagai T; Kakihana K; Miyata Y; Uchida T; Tabata Y; Ogura M
    Jpn J Clin Oncol; 2013 Dec; 43(12):1177-83. PubMed ID: 24130086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.
    Knoebel RW; McQuary A; Becker P; Hendrie P; Petersdorf S; Appelbaum FR; Estey E
    Leuk Res; 2011 Sep; 35(9):e164-6. PubMed ID: 21684006
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of Clofarabine in the treatment of adults with acute myeloid leukemia.
    Fozza C
    Crit Rev Oncol Hematol; 2015 Mar; 93(3):237-45. PubMed ID: 25457773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant.
    Loeffler C; Kapp M; Grigoleit GU; Mielke S; Loeffler J; Heuschmann PU; Malzahn U; Hupp E; Einsele H; Stuhler G
    Leuk Lymphoma; 2015; 56(12):3365-9. PubMed ID: 26014275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes.
    Roberts DA; Wadleigh M; McDonnell AM; DeAngelo DJ; Stone RM; Steensma DP
    Leuk Res; 2015 Feb; 39(2):204-10. PubMed ID: 25554239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia.
    Büttner B; Knoth H; Kramer M; Oertel R; Seeling A; Sockel K; von Bonin M; Stölzel F; Alakel N; Platzbecker U; Röllig C; Ehninger G; Bornhäuser M; Schetelig J; Middeke JM
    Leuk Lymphoma; 2017 Dec; 58(12):2865-2874. PubMed ID: 28509593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia.
    Fontanelli G; Rocco M; Caracciolo F; Benedetti E; Buda G; Orciuolo E; Carulli G; Galimberti S; Azzarà A; Petrini M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e13-7. PubMed ID: 24144836
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.
    Tse E; Leung AY; Sim J; Lee HK; Liu HS; Yip SF; Kwong YL
    Ann Hematol; 2011 Nov; 90(11):1277-81. PubMed ID: 21455604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine-induced kidney toxicity.
    Jhaveri KD; Chidella S; Allen SL; Fishbane S
    J Oncol Pharm Pract; 2014 Aug; 20(4):305-8. PubMed ID: 24081220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine: a size that fits all, may not fit all.
    Vij R
    Leuk Lymphoma; 2009 Mar; 50(3):309-10. PubMed ID: 19347718
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofarabine-based consolidation therapy in AML.
    Brower V
    Lancet Oncol; 2017 Apr; 18(4):e201. PubMed ID: 28262461
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
    Larson ML; Venugopal P
    Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation.
    Long-Boyle J; Huang J; Rydholm N; Smith A; Orchard P; Tolar J; Jacobson P
    J Clin Pharmacol; 2011 May; 51(5):679-86. PubMed ID: 20525919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
    Tran H; Yang D
    Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
    Koh K; Ogawa C; Okamoto Y; Kudo K; Inagaki J; Morimoto T; Mizukami H; Ecstein-Fraisse E; Kikuta A
    Int J Hematol; 2016 Aug; 104(2):245-55. PubMed ID: 27086352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
    Molteni A; Riva M; Ravano E; Marbello L; Mancini V; Grillo G; Zucchetti E; Greco R; Cairoli R
    Int J Hematol; 2017 Jun; 105(6):769-776. PubMed ID: 28220349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia.
    Abbi KK; Rybka W; Ehmann WC; Claxton DF
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):41-6. PubMed ID: 25085441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.